Publications

Liquid biopsies could be superior to tumor biopsy to provide a molecular profile in non-small cell lung cancer (NSCLC) patients

Authors: J Remon, L Lacroix, D Planchard, C Pannet, C Jovelet, A Lawson, S Smalley, ...

E-pub date: 1 Feb 2016

Journal name: Journal of Thoracic Oncology

Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.

Authors: OS Walker, SJ Elsässer, M Mahesh, M Bachman, S Balasubramanian, JW Chin

E-pub date: 27 Jan 2016

Journal name: J Am Chem Soc

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D-E H...

E-pub date: 22 Jan 2016

Journal name: Angew Chem Int Ed Engl

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D-E H...

E-pub date: 22 Jan 2016

Journal name: Angew Chem Weinheim Bergstr Ger

Rücktitelbild: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. 4/2016)

Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D Hu,...

E-pub date: 22 Jan 2016

Journal name: Angewandte Chemie

Back Cover: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. Int. Ed. 4/2016)

Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D Hu,...

E-pub date: 22 Jan 2016

Journal name: Angewandte Chemie International Edition

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

Authors: S Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, M Janiszewska, ...

E-pub date: 21 Jan 2016

Journal name: Nature

NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.

Authors: IA McNeish, KK Lin, JX Sun, S Goble, A Oza, RL Coleman, CL Scott, G Konecny...

E-pub date: 15 Jan 2016

Journal name: Clinical Cancer Research

Filters

Research Groups

Core Facilities

Start date

End date

Liquid biopsies could be superior to tumor biopsy to provide a molecular profile in non-small cell lung cancer (NSCLC) patients

Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Rücktitelbild: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. 4/2016)

Back Cover: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. Int. Ed. 4/2016)

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Liquid biopsies could be superior to tumor biopsy to provide a molecular profile in non-small cell lung cancer (NSCLC) patients

Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.

Rücktitelbild: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. 4/2016)

Back Cover: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. Int. Ed. 4/2016)

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.